Abbott Laboratories (ABT) Gross Profit (2009 - 2026)

Abbott Laboratories has disclosed Gross Profit across 18 years of filings, most recently posting $6.3 billion for Q1 2026.

• Gross Profit for Q1 2026 came in at $6.3 billion, up 6.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $25.4 billion (up 7.45% YoY), and the FY2025 annual result was $25.0 billion, up 7.59% from the prior year.
• Gross Profit came in at $6.3 billion for Q1 2026 at Abbott Laboratories, down from $6.5 billion in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $6.9 billion in Q1 2022 to a low of $5.4 billion in Q1 2023.
• The 5-year median for Gross Profit is $5.9 billion (2025), against an average of $6.0 billion.
• Across the five-year window, Gross Profit climbed 19.86% in 2022 and slipped 21.6% in 2023, its largest moves.
• Abbott Laboratories' Gross Profit stood at $5.5 billion in 2022, then gained by 3.4% to $5.7 billion in 2023, then increased by 6.1% to $6.0 billion in 2024, then climbed by 8.37% to $6.5 billion in 2025, then dropped by 4.02% to $6.3 billion in 2026.
• The last three Gross Profit figures came in at $6.3 billion (Q1 2026), $6.5 billion (Q4 2025), and $6.3 billion (Q3 2025), per Business Quant data.